K

Kyntra Bio Inc
D

KYNB

7.18000
USD
-0.06
(-0.83%)
مفتوح الان
حجم التداول
44
الربح لكل سهم
-16
العائد الربحي
-
P/E
-1
حجم السوق
29,072,710
المقالات
المزيد

العنوان: Kyntra Bio Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.